A Study of the Safety and Efficacy of Memantine in Moderate to Severe Alzheimer's Disease

NCT00322153 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

677

Enrollment

INDUSTRY

Sponsor class

Conditions

Dementia of the Alzheimer's Type

Interventions

DRUG: memantine ER
DRUG: Placebo

Sponsor

Forest Laboratories